March 27, 2001; 56 (6) Brief Communications
How do AD patients and their caregivers decide whether to enroll in a clinical trial?
Jason H.T. Karlawish, David Casarett, Jennifer Klocinski, Pamela Sankar
First published March 27, 2001, DOI: https://doi.org/10.1212/WNL.56.6.789
Jason H.T. Karlawish
MD
David Casarett
MA, MD
Jennifer Klocinski
MA
How do AD patients and their caregivers decide whether to enroll in a clinical trial?
Jason H.T. Karlawish, David Casarett, Jennifer Klocinski, Pamela Sankar
Neurology Mar 2001, 56 (6) 789-792; DOI: 10.1212/WNL.56.6.789
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 56 no. 6 789-792
PubMed:
Print ISSN:
Online ISSN:
History:
- Received August 14, 2000
- Accepted December 13, 2000
- First Published March 27, 2001.
Copyright & Usage:
© 2001
Author Disclosures
- Jason H.T. Karlawish, MD,
- David Casarett, MA, MD,
- Jennifer Klocinski, MA and
- Pamela Sankar, PhD
- Jason H.T. Karlawish, MD,
- David Casarett, MA, MD,
- Jennifer Klocinski, MA and
- Pamela Sankar, PhD
- From the Departments of Medicine (Drs. Karlawish and Casarett), Molecular and Cellular Engineering (Dr. Sankar), and Sociology (J. Klocinski), The University of Pennsylvania; the Division of Geriatrics (Drs. Karlawish and Casarett); the Alzheimer’s Disease Center (Dr. Karlawish); the Center for Bioethics (Drs. Karlawish, Casarett, and Sankar); the Philadelphia Veteran’s Administration Medical Center (Dr. Casarett); and the Institute on Aging (Drs. Karlawish and Casarett), Philadelphia, PA.
- Address correspondence and reprint requests to Dr. Karlawish, Institute on Aging, 3615 Chestnut Street, Philadelphia, PA 19104; e-mail: Jasonkar{at}mail.med.upenn.edu
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Alert Me
Recommended articles
-
Articles
Caregiving in progressive supranuclear palsyBob Uttl, Pilar Santacruz, Irene Litvan et al.Neurology, November 01, 1998 -
Articles
The effect of noninvasive ventilation on ALS patients and their caregiversN. Mustfa, E. Walsh, V. Bryant et al.Neurology, April 24, 2006 -
Views & Reviews
Palliative care and neurologyTime for a paradigm shiftIsabel Boersma, Janis Miyasaki, Jean Kutner et al.Neurology, July 02, 2014 -
Articles
Trends and determinants of end-of-life practices in ALS in the NetherlandsM. Maessen, J. H. Veldink, B. D. Onwuteaka-Philipsen et al.Neurology, September 21, 2009